[go: up one dir, main page]

TR200602727A2 - Cilt defektleri ve yaşlanması tedavisinde kullanılacak bir yöntem ve bir doku maddesi - Google Patents

Cilt defektleri ve yaşlanması tedavisinde kullanılacak bir yöntem ve bir doku maddesi

Info

Publication number
TR200602727A2
TR200602727A2 TR2006/02727A TR200602727A TR200602727A2 TR 200602727 A2 TR200602727 A2 TR 200602727A2 TR 2006/02727 A TR2006/02727 A TR 2006/02727A TR 200602727 A TR200602727 A TR 200602727A TR 200602727 A2 TR200602727 A2 TR 200602727A2
Authority
TR
Turkey
Prior art keywords
treatment
aging
skin defects
tissue substance
human skin
Prior art date
Application number
TR2006/02727A
Other languages
English (en)
Inventor
Tun� T�Ryak� Kemal
Original Assignee
Tun� T�Ryak� Kemal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tun� T�Ryak� Kemal filed Critical Tun� T�Ryak� Kemal
Priority to TR2006/02727A priority Critical patent/TR200602727A2/tr
Priority to PCT/TR2007/000046 priority patent/WO2007139525A2/en
Publication of TR200602727A2 publication Critical patent/TR200602727A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Buluş, sağlık endüstrisinde, tedavi ya da yaşlanma sürecinin sonucu olarak ortaya çıkan problemlerin çözümü için, bir insan deri hücresi olan fibroblastların kişilerden alınıp laboratuar ortamında kültüre edilmesi (otolog kültüre fibroblastlar) ve bu hücrelerin yine insan cildinde var olan bir madde olan hyalüronik asitten oluşan taşıyıcı medyum içine yerleştirilerek hazırlanan ürünün kişiye geri enjeksiyonu ile ilgilidir.
TR2006/02727A 2006-05-31 2006-05-31 Cilt defektleri ve yaşlanması tedavisinde kullanılacak bir yöntem ve bir doku maddesi TR200602727A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2006/02727A TR200602727A2 (tr) 2006-05-31 2006-05-31 Cilt defektleri ve yaşlanması tedavisinde kullanılacak bir yöntem ve bir doku maddesi
PCT/TR2007/000046 WO2007139525A2 (en) 2006-05-31 2007-05-24 A method and a tissue material for use in the treatment of the skin defects and aging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2006/02727A TR200602727A2 (tr) 2006-05-31 2006-05-31 Cilt defektleri ve yaşlanması tedavisinde kullanılacak bir yöntem ve bir doku maddesi

Publications (1)

Publication Number Publication Date
TR200602727A2 true TR200602727A2 (tr) 2007-12-24

Family

ID=38457921

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2006/02727A TR200602727A2 (tr) 2006-05-31 2006-05-31 Cilt defektleri ve yaşlanması tedavisinde kullanılacak bir yöntem ve bir doku maddesi

Country Status (2)

Country Link
TR (1) TR200602727A2 (tr)
WO (1) WO2007139525A2 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070122315A (ko) * 2006-06-26 2007-12-31 (주) 에스바이오메딕스 자가 진피 세포 및 히알루론산을 함유하는 주사용 인체연조직 충전제 조성물
CN108956249B (zh) * 2018-05-23 2020-11-17 青岛市市立医院 一种医疗用漂烘装置
CN116870254B (zh) * 2023-07-31 2024-02-09 白晋 人自体胶原蛋白活细胞注射剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591444A (en) * 1995-07-28 1997-01-07 Isolagen Technologies, Inc. Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
IT1302534B1 (it) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
JP2008542252A (ja) * 2005-05-26 2008-11-27 インターサイテックス リミティド 同種真皮繊維芽細胞を用いる組織修復

Also Published As

Publication number Publication date
WO2007139525A2 (en) 2007-12-06
WO2007139525A3 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
Vallmajo‐Martin et al. PEG/HA hybrid hydrogels for biologically and mechanically tailorable bone marrow organoids
Bisson et al. Irradiated human dermal fibroblasts are as efficient as mouse fibroblasts as a feeder layer to improve human epidermal cell culture lifespan
Zerbinati et al. In vitro evaluation of the biosafety of hyaluronic acid PEG cross-linked with micromolecules of calcium hydroxyapatite in low concentration
EA200970110A1 (ru) Производные 6,9-дизамещённого пурина и их применение для лечения кожи
Yoon et al. Different effects of resveratrol on early and late passage mesenchymal stem cells through β-catenin regulation
NZ609460A (en) Method for activating helper t cell
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
GB2467467B (en) TAZ/WWTR1 for diagnosis and treatment of cancer
DE602005026143D1 (de) Erkennung eines erhöhten spiegels von her-2/neu-proteinen in zirkulierenden krebszellen und dessen behandlung
Farnsworth et al. The role of the PCM in reducing oxidative stress induced by radical initiated photoencapsulation of chondrocytes in poly (ethylene glycol) hydrogels
MX366369B (es) Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo.
MX2016005824A (es) Metodo de cultivo celular.
Bonifacio et al. Insights into Arbutin effects on bone cells: Towards the development of antioxidant titanium implants
Letsiou et al. In vitro protective effects of marine-derived Aspergillus puulaauensis TM124-S4 extract on H2O2-stressed primary human fibroblasts
TR200602727A2 (tr) Cilt defektleri ve yaşlanması tedavisinde kullanılacak bir yöntem ve bir doku maddesi
Dan et al. Dynamic imaging reveals coordinate effects of cyclic stretch and substrate stiffness on endothelial integrity
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
WO2004011631A3 (en) Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
Almeida et al. Perfusion and ultrasonication produce a decellularized porcine whole-ovary scaffold with a preserved microarchitecture
Antonyshyn et al. Limited endothelial plasticity of mesenchymal stem cells revealed by quantitative phenotypic comparisons to representative endothelial cell controls
Wu et al. Carbon dots crosslinked egg white hydrogel for tissue engineering
Pazmandi et al. Modulatory effects of low-dose hydrogen peroxide on the function of human plasmacytoid dendritic cells
EP4235175A3 (en) Methods for culturing human keratinocytes
ATE544849T1 (de) Aktivierte dendritische zellen, therapieverfahren unter verwendung der dendritischen zellen sowie verfahren zur kultivierung von gamma-delta-t- zellen
CN101485905B (zh) 一种构建组织工程皮肤的方法